Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

RNA Therapeutics: How Far Have We Gone?

Coutinho MF, Matos L, Santos JI, Alves S.

Adv Exp Med Biol. 2019;1157:133-177. doi: 10.1007/978-3-030-19966-1_7. Review.

PMID:
31342441
2.

Correction of a Splicing Mutation Affecting an Unverricht-Lundborg Disease Patient by Antisense Therapy.

Matos L, Duarte AJ, Ribeiro D, Chaves J, Amaral O, Alves S.

Genes (Basel). 2018 Sep 11;9(9). pii: E455. doi: 10.3390/genes9090455.

3.

Erratum to "Resveratrol Attenuates Copper-Induced Senescence by Improving Cellular Proteostasis".

Matos L, Gouveia AM, Almeida H.

Oxid Med Cell Longev. 2017;2017:9172085. doi: 10.1155/2017/9172085. Epub 2017 Sep 24.

4.

Genetic Substrate Reduction Therapy: A Promising Approach for Lysosomal Storage Disorders.

Coutinho MF, Santos JI, Matos L, Alves S.

Diseases. 2016 Nov 9;4(4). pii: E33. doi: 10.3390/diseases4040033. Review.

5.

Follicular Fluid redox involvement for ovarian follicle growth.

Freitas C, Neto AC, Matos L, Silva E, Ribeiro Â, Silva-Carvalho JL, Almeida H.

J Ovarian Res. 2017 Jul 12;10(1):44. doi: 10.1186/s13048-017-0342-3. Review.

6.

Resveratrol Attenuates Copper-Induced Senescence by Improving Cellular Proteostasis.

Matos L, Gouveia AM, Almeida H.

Oxid Med Cell Longev. 2017;2017:3793817. doi: 10.1155/2017/3793817. Epub 2017 Feb 9. Erratum in: Oxid Med Cell Longev. 2017;2017:9172085.

7.

Data in support of a functional analysis of splicing mutations in the IDS gene and the use of antisense oligonucleotides to exploit an alternative therapy for MPS II.

Matos L, Gonçalves V, Pinto E, Laranjeira F, Prata MJ, Jordan P, Desviat LR, Pérez B, Alves S.

Data Brief. 2015 Oct 28;5:810-7. doi: 10.1016/j.dib.2015.10.011. eCollection 2015 Dec.

8.

Functional analysis of splicing mutations in the IDS gene and the use of antisense oligonucleotides to exploit an alternative therapy for MPS II.

Matos L, Gonçalves V, Pinto E, Laranjeira F, Prata MJ, Jordan P, Desviat LR, Pérez B, Alves S.

Biochim Biophys Acta. 2015 Dec;1852(12):2712-21. doi: 10.1016/j.bbadis.2015.09.011. Epub 2015 Sep 25.

9.

Antioxidant Supplementation Modulates Age-Related Placental Bed Morphology and Reproductive Outcome in Mice.

Silva E, Soares AI, Costa F, Castro JP, Matos L, Almeida H.

Biol Reprod. 2015 Sep;93(3):56. doi: 10.1095/biolreprod.114.127746. Epub 2015 Jul 15.

PMID:
26178715
10.

Reference ranges for uterine artery pulsatility index during the menstrual cycle: a cross-sectional study.

Guedes-Martins L, Gaio R, Saraiva J, Cerdeira S, Matos L, Silva E, Macedo F, Almeida H.

PLoS One. 2015 Mar 5;10(3):e0119103. doi: 10.1371/journal.pone.0119103. eCollection 2015.

11.

Therapeutic strategies based on modified U1 snRNAs and chaperones for Sanfilippo C splicing mutations.

Matos L, Canals I, Dridi L, Choi Y, Prata MJ, Jordan P, Desviat LR, Pérez B, Pshezhetsky AV, Grinberg D, Alves S, Vilageliu L.

Orphanet J Rare Dis. 2014 Dec 10;9:180. doi: 10.1186/s13023-014-0180-y.

12.

From bedside to cell biology: a century of history on lysosomal dysfunction.

Coutinho MF, Matos L, Alves S.

Gene. 2015 Jan 15;555(1):50-8. doi: 10.1016/j.gene.2014.09.054. Epub 2014 Sep 29. Review.

PMID:
25275857
13.

ER Stress Response in Human Cellular Models of Senescence.

Matos L, Gouveia AM, Almeida H.

J Gerontol A Biol Sci Med Sci. 2015 Aug;70(8):924-35. doi: 10.1093/gerona/glu129. Epub 2014 Aug 22.

PMID:
25149687
14.

Copper ability to induce premature senescence in human fibroblasts.

Matos L, Gouveia A, Almeida H.

Age (Dordr). 2012 Aug;34(4):783-94. doi: 10.1007/s11357-011-9276-7. Epub 2011 Jun 22.

15.

Caspase-3 and Bcl-2 expression in aging in adrenal zona reticularis after dexamethasone administration.

Almeida H, Matos L, Neves D.

Ann N Y Acad Sci. 2007 Nov;1119:190-5.

PMID:
18056966
16.

Age-related effects of dexamethasone administration in adrenal zona reticularis.

Almeida H, Matos L, Ferreira J, Neves D.

Ann N Y Acad Sci. 2006 May;1067:354-60.

PMID:
16804011

Supplemental Content

Loading ...
Support Center